S ince the late 1980s, the signal-averaged electrocardiography (SAECG) has been used for assessment of the risk for sudden cardiac death in patients after myocardial infarction. 1, 2 It is believed that the late potentials (LPs) in the terminal portion of the averaged QRS complex represent the slow and inhomogeneous intraventricular conduction as a consequence of the myocardial scarring. The tissue derangements in the areas of healing myocardial infarction may serve as a prerequisite for the occurrence of re-entry ventricular tachycardia (VT). Ablation techniques aiming at the elimination of the endocardial LPs and scar homogenization have been proven effective in treating VT. [3] [4] [5] [6] Although the VT noninducibility after catheter ablation (CA) is commonly used as a procedural end point, some important limitations question the role of programmed ventricular stimulation (PVS) as a proof of long-term success after ablation. [7] [8] [9] We suggested that the LPs in SAECG correlate with the endocardial scar area and LPs in electro-anatomic maps of patients with ischemic cardiomyopathy. Further, we hypothesized that substrate-guided ablation and abolition of the endocardial LPs can result in normalization of the SAECG. This way, SAECG may be used as an additional noninvasive end point and predictor of success after VT ablation. SAECG for Outcomes After Ablation of Ischemic VT to record 250 complexes. Each lead was filtered using a bidirectional filter at 40 to 250 Hz. The 3 filter signals were then combined into a vector magnitude (X2+Y2+Z2)1/2. The noise level <0.4 μV was set up for all cases. Criteria for abnormal SAECG were defined as follows: (1) filtered QRS (fQRS) complex ≥114 ms; (2) root mean square voltage in the last 40 ms of the fQRS (RMS 40) <20 μV; and (3) duration of low-amplitude potentials <40 μV (LAS 40) >38 ms. 10 Patient with at least 2 abnormal criteria were defined as having positive SAECG. In patients with pacemakers or cardiac resynchronization therapy devices, a reprogramming of the device with inhibition of the pacemaker function was performed to obtain the SAECG. The SAECG was performed before CA and usually repeated on the next day after CA.
Electrophysiological Study
Before the CA, all patients signed an informed consent for undergoing the procedure. The preparation of the patients was performed according to the clinical routine at our institution. At the beginning of the CA, we measured the duration of the unfiltered QRS complex at 200 mm/s. The primary mapping approach was endocardial in most of the cases. After a single transseptal puncture, a steerable sheath (Agilis, St Jude Medical) was used to introduce the ablation catheter. All patients were administered heparin intravenously to achieve an activated clotting time ≥300 seconds. At the beginning of the procedure, a PVS was performed to induce the clinical VT.
Electro-Anatomic Mapping and CA
Electro-anatomic voltage mapping (EAM) in sinus rhythm was performed to delineate the underlying substrate using EAM system (Carto; Biosense Webster Inc, Diamond bar, CA). Point-by-point acquisition was performed using 7 F, 3.5 mm tipped ablation catheters (Navistar Thermocool; Biosense Webster Inc, CA) with a 2-5-2 mm interelectrode distance. While creating the voltage maps, we rely mainly on the automatic annotation. We used the standard filter settings (16-500 Hz) for the bipolar Carto signals. The fill threshold was set up at 15. For the purpose of activation mapping, manually corrected annotation of the signals was used. Additionally, all points were manually inspected, and those who were inside in relation to the outer surface were deleted. The catheter-to-tissue contact was additionally assessed using the signal characteristics (fragmentation, sharpness) and amplitude. Particular attention was paid on the point density in the areas of interest. The median number of the points was 200 (quartiles 100-300) points. In particular, high-density mapping was performed in areas demonstrating low-voltage and fragmented signals, and respectively, in areas with
WHAT IS KNOWN
• Signal-averaged ECG is adopted as a tool for assessment of the risk for ventricular tachycardia in patients after myocardial infarction.
• Previous studies reported that a surgical scar resection can result in normalization of the signal-averaged ECG
WHAT THE STUDY ADDS
• The radiofrequency catheter ablation of ventricular tachycardia can lead to normalization of the signalaveraged ECG. The likelihood for ventricular tachycardia recurrence was significantly lower for patients with normalized signal-averaged ECG after catheter ablation; therefore, it can be used as a noninvasive tool to evaluate the postablation success. high-amplitude signals, a lower point density was required. Local bipolar electrograms, demonstrating peak-to-peak amplitude ≥1.5 mV, were defined as healthy, and low-amplitude signals <0.5 mV were defined as dense scar; potentials with amplitudes between 1.5 and 0.5 mV were defined as border zone. The surface of the bipolar low-voltage area (LVA) and endocardial unipolar-voltage area <8.3 mV was measured. Particular attention was paid on localization of double potential and LP. In patients with hemodynamically stable VTs, activation and entrainment mapping were performed to characterize the exit sites and critical isthmuses of VT. We used power settings of ≤50 W and irrigation rates of ≤30 mL/min for ablation. After CA, PVS was performed to reinduce VTs. Because of the frequent impossibility to define the clinical VT because of the absence of 12-lead ECG documentation or presence of multiple VTs in the implantable cardioverter defibrillator memory, the complete VT noninducibility was adopted as an end point and a proof for procedural success. Additionally, we aimed to achieve the abolition of all discrete LPs.
Study End Point and Patient's Follow-Up
The primary end point was freedom from any sustained VT. Data on VT recurrences, device therapies, and current antiarrhythmic drugs medications were collected through device interrogations every 3 months or earlier in case of implantable cardioverter defibrillator therapies. Mortality data were confirmed via telephone contact with the referring cardiologists or primary care physicians.
Statistical Analysis
Continuous variables with normal distribution are reported as mean±standard deviation, whereas categorical variables are reported as absolute numbers and proportions. Student t test, Chi square, and Fischer's exact test were used to compare differences across groups. The differences between fQRS, LAS 40, and RMS 40 before and after ablation were compared using a paired t test. The McNemar and Wilcoxon signed-rank tests were used to compare the SAECG normalization before and after CA. The VT-free survival during the follow-up period was estimated by the Kaplan-Meier method, and log-rank statistics was used to compare the survival curves. The bivariate Pearson correlation was used to investigate the association between the size of BVA and the SAECG. All tests were 2-sided, and P values <0.05 were considered statistically significant. The statistical analysis was performed using SPSS 20.0 (IBM, Armonk, NY).
Results

Baseline Characteristics
Fifty patients (42 male; mean age 67±10 years, mean ejection fraction 34±12%) with ischemic cardiomyopathy and sustained VTs were included in the study. Forty-two (84%) patients had previous myocardial infarction; of them, 19 patients had prior anterior or antero-septal infarction. Thirtytwo patients had narrow QRS complex. Two (4%) had left bundle-branch block. The other baseline clinical characteristics are presented in Table 1 .
SAECG Characteristics Before and After Ablation
Using the above mentioned criteria, SAECG was defined as abnormal in 40 (80%) patients before ablation; of them, 34 (68%) patients had 3 abnormal SAECG criteria and 6 (12%) patients had 2 abnormal SAECG criteria. Seven (14%) patients had 1 positive SAECG criterion, and 3 (6%) patients had entirely normal SAECG. Altogether, 10 (20%) patients had negative SAECG before CA. After CA, 30 patients (60%) remained positive by 3 and 4 patients (8%) remained positive by 2 SAECG criteria. Additionally, 12 (24%) patients had one positive criterion, and 4 (8%) patients had no abnormal SAECG criteria after CA. Altogether, there were 16 (32%) patients with normal SAECG (≤1 criteria) The presented results are mean±SD. fQRS indicates filtered QRS; LAS, lowamplitude potentials; RMS, root mean square; and VT, ventricular tachycardia. Figure 3 . Correlation between filtered QRS (fQRS) and endocardial low-voltage (LV) area in the overall studied cohort (A) and in the subgroup of patients with normal QRS width (≤120 ms; B) before catheter ablation (CA). SAECG for Outcomes After Ablation of Ischemic VT after CA as compared with 10 (20%) patients with normal SAECG before CA (P=0.058). The observed differences in SAECG before and after CA were not statistically significant ( Figure 1A) .
In 32 patients having narrow QRS complexes, before the CA, 23 (71.9%) patients had 3 abnormal criteria; 2 (6.3%) patients had 2 abnormal criteria; 4 (12.5%) patients had 1 abnormal criterion; and 3 (9.4%) patients had completely normal SAECG. After the CA, 18 (56.3%) patients demonstrated 3 abnormal criteria; 1 (3.1%) patient demonstrated 2 abnormal criteria; 9 (28.1%) patients demonstrated 1 abnormal criterion; and 4 (12.5%) patients demonstrated no abnormal SAECG (P=0.039). Altogether, normal SAECG was observed in 13 patients after CA as compared with 7 initially normal SAECG patients (40.6% versus 21.9%; P=0.034; Figure 1B) .
In all 6 cases exhibiting SAECG normalization, both LAS 40 and RMS 40 improved; however, the fQRS duration remained unchanged. An example of SAECG improvement after CA is depicted in Figure 2 . Comparing the mean values of each of the SAECG components, there were no statistically significant differences in the fQRS, LAS 40, and RMS 40 before and after CA ( Table 2 ).
Correlations Between the SAECG and the Bipolar Electro-Anatomic Voltage Maps
In the overall cohort, significant positive correlations were found only between the bipolar LVA (<1.5 mV) in EAM and fQRS before CA (r=0.414; P=0.003; Figure 3A ). There was no correlation between the fQRS and the dense scar area (r=0.220; P=0.146). Also, in the subgroup with QRS ≤120 ms, a significant correlation (r=0.345; P=0.049) was observed between fQRS before CA and the LVA (<1.5 mv; Figure 3B ). Examples of EAM and the corresponding SAECG recordings are depicted in Figure 4 . 
Effects of Scar Localization on the SAECG Parameters
In patients having anterior or septal scars, the mean RMS 40 before CA was less abnormal than the mean RMS 40 in patients having posterior or lateral scars: 22.6±17.5 μV versus 13.7±9.4 μV; P=0.025. There was also a trend toward less abnormal LAS 40 in patients with anterior or septal scar localization: 48.5±21.9 ms versus 59.1±21.4 ms; P=0.093. However, patients with anterior and septal scars demonstrated larger LVAs in comparison with those having posterior or lateral scars: 50.4±26.7 cm 2 versus 33.8±21.3 cm 2 ; P=0.018. These differences were more pronounced in patients having narrow QRS complexes (Table 3 ).
SAECG and VT Recurrence After CA
During the median follow-up of 12 (quartiles 3-16) months, the likelihood for VT recurrence was significantly higher in patients having an abnormal SAECG (at least 2 positive criteria) after VT ablation as compared with those having normal or normalized SAECG (hazard ratio=3.64; 95% confidence interval 1.07-12.42; P=0.039; Figure 5A ). Thirty patients without VT recurrence had similar baseline characteristics as the 20 patients with VT recurrence (Table 4 ). In the subgroup with QRS ≤120 ms, the probability for VT recurrence was also higher in patients having persistently abnormal SAECG after CA (hazard ratio=5.80; 95% confidence interval 1.29-26.18; P=0.022; Figure 5B ). In the subgroup of patients having narrow QRS complexes, the fQRS width and the LAS 40 were significant predictors for VT recurrence with hazard ratio=1.03; 95% confidence interval 1.01-1.05; P=0.011 and hazard ratio=1.024; 95% confidence interval 1.002-1.046; P=0.03, for each millisecond, respectively.
Mortality and SAECG
During the follow-up period, 3 patients died. Two of them had early VT recurrence (<3 days after CA), and 1 experienced a VT 51 days after the CA. Those who died had significantly worse left ventricular (LV) ejection fraction (17±2% versus 35±12%; P=0.011) and larger LV end-diastolic volumes (300±32 versus 189±58 mL; P=0.003) as compared with the survivals. The patients who died had larger borderline and dense scar areas in EAM: 78±29 versus 38±23 cm 2 ; P=0.007 and 32±26 versus 13±13 cm 2 ; P=0.026, respectively. All 3 patients had abnormal SAECG (3 abnormal criteria) before and after CA and no significant improvement of the fQRS, LAS 40, and RMS 40 after CA.
Discussion
The SAECG is a recognized tool for evaluation of the risk of VT and sudden cardiac death in patients after myocardial infarction. 1, 2, 11, 12 The role of SAECG was extensively studied in a variety of clinical conditions, such as dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, heart transplantation, congenital heart defects, and so forth. [13] [14] [15] [16] [17] [18] The low-voltage potentials recorded in the terminal portion of the amplified and fQRS complex indicate the presence of a nonuniform, slow myocardial conduction that may serve as a substrate for VT. In the present study, we aimed to find out if there is a correlation between the LPs recorded in the surface SAECG and the endocardial LV scar in patients referred for VT ablation. We hypothesize that elimination of the endocardial LPs through CA can result in normalization of the SAECG and can be eventually used as a noninvasive tool for assessment of the long-term procedural success.
In a cohort of 50 post-myocardial infarction patients with a recurrent VT, significant correlations between the pre-and postablation fQRS and the size of the endocardial LV LVA (<1.5 mV) were observed. However, although frequently containing low-voltage and fragmented signals, the size of the compact scar (<0.5 mV) showed no significant correlation with the fQRS. Furthermore, no significant correlations could be proved between the RMS 40, the LAS 40, and the endocardial bipolar LVA (<1.5 mV). Therefore, it seems that the width of the fQRS in SAECG is influenced by the overall infarct area and, especially, by the conduction delay in the inhomogeneous borderline zone of the scar (0.5-1.5 mV), containing mostly double but relatively high-amplitude potentials. Notably, in those cases where SAECG normalized after CA, the observed improvement was mainly because of a normalization of the LAS 40 and the RMS, whereas width of the fQRS remained unchanged. These findings are not surprising because the CA aims at elimination of the late, low-amplitude signals located in conduction channels inside the dense scar, but it is not expected to decrease the size of the diseased myocardium. It seems that through CA, it is possible to modify the electric inhomogeneity of the scar, which, in turn, can result in the disappearance of the LPs in the SAECG.
Notably, the localization of the scar does seem to affect the SAECG recordings. The abnormal LAS 40 and RMS 40 were less pronounced in the patients with anterior or septal scars, even if they demonstrated larger border zone areas in EAM. Because it is doubtful that the patients with larger LVAs have less LPs, it seems that other factors may interfere with the SAECG recordings. We suppose that because of the earlier septal LV activation preceding that of the lateral LV, some septally or anteriorly located LPs may be obscured by the activation of the rest of the LV. Presumably, the predictive power of the SAECG would be greater in patients with inferior or lateral scars.
Previously, Twidale et al studied 4 patients with noninducible VTs after CA of ischemic VT and demonstrated that LPs persist even after CA. Furthermore, one of the 4 patients had repeatedly inducible VT, with PVS performed 2 weeks after the initial ablation. The authors concluded that SAECG was apparently not useful for predicting the outcomes after VT ablation. 19 Obviously, the small studied group, the shorter follow-up period, and the underdeveloped 3D mapping technology at that time were major limitations of the study. In spite of its negative results, this study introduced the idea that VT ablation may eventually lead to normalization of the SAECG. In our study, the fQRS, LAS 40, and RMS 40 as a whole did not change significantly as compared with their baseline values. However, in some patients, a significant improvement in fQRS, LAS 40, and RMS 40 was observed, leading to normalization of the initially abnormal SAECG. Importantly, the patients having normal or normalized SAECG after CA had significantly longer VT-free survival as compared with those having persistently abnormal SAECG. The likelihood for VT recurrence during the follow-up was 3.6× higher in patients with persistently abnormal SAECG after CA. Previously, Perloff et al 20 reported on similar observations in patients after right ventriculotomy for intracardiac repair of tetralogy of Fallot. They showed that CA or the surgical revision of a ventriculotomy scar can render a positive SAECG result negative. Similarly, Marcus et al 21 observed a shortening of the fQRS and disappearance of the LAS 40 in patients after surgical scar resection. In another smaller study from Breithardt et al in 7 post-myocardial infarction patients with VT, the surgical scar resection resulted in normalization of the SAECG and noninducibility of the clinical VT in 6 cases. They proposed that SAECG can be used for noninvasive assessment of the efficacy of the surgery in patients with post-myocardial infarction VT. 22 The normalization of the SAECG after CA can be used as an adjunct to the generally accepted PVS protocols to evaluate the acute procedural success because these 2 methods evaluate different aspects of the VT pathophysiology. Although the PVS assesses indirectly the capability of the arrhythmogenic substrate to sustain reentry VTs, the LPs in SAECG visualize the heterogeneity and the myocardial conduction delay within the scar area. Moreover, in contrast with the PVS, SAECG as a noninvasive tool can be used repeatedly without any procedure-related hazards to assess the odds for VT recurrences. In addition, because there are substantial variations in the PVS protocols between different electrophysiological laboratories, using the SAECG as an end point may simplify the comparison of the procedural results worldwide. Finally, although both methods are prone to certain limitations, combining them, we can overcome the disadvantages of each one.
Study Limitations
The small number and the relatively short follow-up of the patients are limitations of the study, and therefore, it should be considered as a hypothesis-generating one. However, even in this small cohort, the observed effect of SAECG normalization on VT recurrence was significant. The presented results are valid for patients with ischemic heart disease and must be confirmed in other clinical conditions, such as dilated cardiomyopathy, arrhythmogenic right ventricular dysplasia, and so forth. As long as the postablation SAECGs were recorded before the hospital discharge, it remains unclear if the VT recurrences during the follow-up were accompanied by perturbations in the SAECG. The localization of the scar may influence the sensitivity of the method because the abnormal LAS 40 and RMS 40 were less pronounced in patients with anterior or septal myocardial infarctions.
Conclusions
In patients with ischemic VT, the fQRS width in SAECG correlated significantly with the size of the endocardial scar. A successful CA can result in normalization of the SAECG. A normalization of the SAECG after ablation of VT is associated with more favorable long-term outcomes. The SAECG can be useful to assess the procedural success after VT ablation.
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